Pharmaceuticals

Discovering the Need for RNA Vaccines: Q&A with Thomas Rademacher, MD

bexib
By bexib 0 Min Read

Rademacher talks about his early efforts to develop a vaccine for the Ebola virus.

You Might Also Like

The FDA has approved Genmab’s Epkinly for the treatment of adults with follicular lymphoma that has relapsed or is refractory after two or more lines of systemic therapy.

Premera Blue Cross appoints Dr. Romila Batra as Chief Medical Officer

Movano Health Announces Addition of Deep Learning Software to Its AI-Powered Heart Rate Monitoring Software

Evaluation of LP-284 using RADR for NHL and other targeted cancers

Pharmaceutical R&D bets: picking pipeline winners in a risky field

Share This Article
Previous Article Are radical climate activists like Extinction Rebellion and Just Stop Oil actually pawns of the fossil fuel industry?
Next Article Learning from 20 years of double cropping – RealAgriculture
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

What to watch out for during state, Treasury, and OMB confirmation hearings
Manufacturing
TCH cross-border payments on hold
Banking
Adafruit Hit 800 Open Source Hardware Certification
Manufacturing
20 CUs to be introduced on InvestiFi’s securities platform in 2025
Banking